Refocus Group Analysis
Refocus' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Refocus' financial risk is the risk to Refocus stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Refocus' debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Refocus is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Refocus to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Refocus is said to be less leveraged. If creditors hold a majority of Refocus' assets, the OTC Stock is said to be highly leveraged.
Refocus Group is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Refocus otc analysis is to determine its intrinsic value, which is an estimate of what Refocus Group is worth, separate from its market price. There are two main types of Refocus' stock analysis: fundamental analysis and technical analysis.
The Refocus otc stock is traded in the USA on OTCGREY Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Refocus |
Refocus OTC Stock Analysis Notes
The company recorded a loss per share of 0.2. Refocus Group had not issued any dividends in recent years. Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company was founded in 1994 and is based in Dallas, Texas. Refocus operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for Refocus Group is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Refocus Group contact the company at 214-368-0200 or learn more at https://www.refocus-group.com.Refocus Group Investment Alerts
| Refocus Group is not yet fully synchronised with the market data | |
| Refocus Group has some characteristics of a very speculative penny stock | |
| Refocus Group has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (4.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Refocus Group currently holds about 3.08 M in cash with (4.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. |
Refocus Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 247.92 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Refocus's market, we take the total number of its shares issued and multiply it by Refocus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Refocus Group Debt to Cash Allocation
Many companies such as Refocus, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has a current ratio of 3.17, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Refocus until it has trouble settling it off, either with new capital or with free cash flow. So, Refocus' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Refocus Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Refocus to invest in growth at high rates of return. When we think about Refocus' use of debt, we should always consider it together with cash and equity.Refocus Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Refocus' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Refocus, which in turn will lower the firm's financial flexibility.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Refocus to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. Note that the Refocus Group information on this page should be used as a complementary analysis to other Refocus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Refocus OTC Stock
If you are still planning to invest in Refocus Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Refocus' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |